Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 19/20 | 0.56 |
| ▸ | CTSL | P07711 | 9/20 | 0.55 |
| ▸ | CTSB | P07858 | 2/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 5/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12204063 | 0.80 | CTSS (0.59) | CTSSCTSLCTSBPKMSMN1; SMN2 | |
| SCHEMBL6876245 | 0.78 | CTSS (0.64) | CTSSCTSLCTSBPKMSMN1; SMN2 | |
| SCHEMBL1867207 | 0.77 | CTSS (0.54) | CTSSCTSLCTSBPKMSMN1; SMN2 | |
| SCHEMBL15047871 | 0.77 | PKM (0.50) | CTSSCTSLCTSBPKMSMN1; SMN2 | |
| Lithium Ion SCHEMBL5523630 | 0.76 | CTSS (0.61) | CTSSCTSLCTSBPKMSMN1; SMN2 | |
| SCHEMBL3602438 | 0.75 | CTSS (0.55) | CTSSCTSLCTSBPKMSMN1; SMN2 | |
| SCHEMBL14987883 | 0.75 | CTSS (0.55) | CTSSCTSLCTSBPKMSMN1; SMN2 | |
| SCHEMBL7399592 | 0.74 | CTSS (0.69) | CTSSCTSLCTSB | |
| SCHEMBL5523884 | 0.73 | CTSS (0.73) | CTSSCTSLCTSBCTSK | |
| SCHEMBL5523879 | 0.72 | CTSS (0.66) | CTSSCTSLCTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8729114-B2 | Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-S | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-05-20 | — | — | US | disclosed |
| US-20130158018-A1 | Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130158018-A1 | Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S | CTSS, CTSV, CTSF | CTSS 1/4885CTSL 11/4885CTSB 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.